Dialysis Equipment in Utah

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Founded in 1987 and headquartered in South Jordan, Utah, the company employs approximately 7,000 people worldwide and serves hospitals and physicians across the globe. Merit specializes in devices for cardiology, radiology, oncology, critical care, and endoscopy applications. The product portfolio includes catheters, guide wires, balloons, inflation devices, syringes, needles, stents, biopsy tools, drainage systems, embolics and delivery systems, access devices, and monitoring equipment. Merit serves multiple clinical specialties including interventional cardiology, interventional radiology, gastroenterology, critical care, electrophysiology, nephrology, pulmonology, breast surgery, and interventional oncology. The company offers procedural solutions for cardiac catheterization, dialysis access, biopsy procedures, embolotherapy, stricture management, spine interventions, and structural heart applications. Merit operates globally with manufacturing and distribution capabilities supporting complex interventional procedures. The company provides clinician education through Merit's Think Education program and maintains regulatory compliance appropriate for disposable medical devices in the United States and international markets.

Health Line International Corporation is a US manufacturer of vascular access catheters, infusion therapy devices, and related consumables. The company specializes in power-injectable, multi-lumen intravenous catheter kits for adult, pediatric, and neonatal patients. Product lines include PICC line kits (single, double, triple lumen configurations), midline catheter kits, central venous catheter (CVC) kits, hemodialysis catheter kits (tunneled and non-tunneled for temporary, chronic, and permanent dialysis), and IV administration sets (DEHP-free primary, secondary, and extension sets with gravity and pump compatibility). Branded products include SYNERGY CT PICC Line Kits, Health Line CT Midline Catheter Kits, and ORION Central Venous Catheter Kits. The company operates as both a direct manufacturer and OEM supplier to global distribution partners. Health Line emphasizes lean manufacturing, cost-effectiveness, product durability, and patient comfort in catheter design. The company maintains a distributor network model and targets hospital and clinical infusion therapy markets. No specific FDA 510(k), ISO, or CE certifications are mentioned on the fetched content.

Transit Scientific, LLC manufactures minimally invasive vascular intervention devices focused on peripheral vasculature and dialysis access applications. The company's primary product platform is the XO Score® Sheath Platform, an FDA 510(k) and CE Mark cleared device designed for use with percutaneous transluminal angioplasty (PTA) balloons to facilitate dilation and vessel wall apposition in treating stenotic lesions across multiple vascular territories. Indicated applications include iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, as well as obstructive lesions in native or synthetic arteriovenous dialysis fistulae. The company also offers the XO Cross® Catheter Platform, similarly FDA 510(k) and CE Mark cleared, designed to guide and support guidewires during peripheral vascular access, enable wire exchanges, and serve as a delivery conduit for saline solutions or diagnostic contrast agents. The XO Cath microcatheter line extends the portfolio for controlled and selective infusion of diagnostic, embolic, or therapeutic materials into peripheral vessels, with demonstrated clinical use in transradial embolic delivery procedures. All products are cleared for peripheral vascular intervention but explicitly contraindicated for coronary and neuro-vascular applications. Transit Scientific positions itself within the interventional cardiology and peripheral vascular device sector, targeting interventionalists and vascular surgeons managing stenotic disease and dialysis access complications.